Canada Pension Plan Investment Board’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121K Buy
19,300
+5,400
+39% +$50.2K ﹤0.01% 1636
2025
Q4
$170K Buy
+13,900
New +$227K ﹤0.01% 1711

Other funds holding OPRX

Canada Pension Plan Investment Board's OPRX Position: Q1 2026 in Review

Canada Pension Plan Investment Board increased its OptimizeRx (OPRX) stake by 39% in Q1 2026, buying an estimated $50.2K and bringing the position to 19,300 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #1636.

Canada Pension Plan Investment Board first reported a position in OPRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $170K in Q4 2025. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Canada Pension Plan Investment Board held 19,300 shares of OptimizeRx worth $121K as of Q1 2026.
  • Canada Pension Plan Investment Board bought 5,400 OptimizeRx shares in Q1 2026, an estimated $50.2K.
  • OptimizeRx made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1636 holding.
  • Canada Pension Plan Investment Board first reported a position in OptimizeRx in Q4 2025 and has held it in 2 quarters since.
  • Canada Pension Plan Investment Board's OptimizeRx position peaked at $170K in Q4 2025.
  • 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.